tiprankstipranks
Lexaria Bioscience Corp. (LEXX)
:LEXX
US Market

Lexaria Bioscience (LEXX) Income Statement

Compare
194 Followers

Lexaria Bioscience Income Statement

Last quarter (Q1 2025), Lexaria Bioscience's total revenue was $183.92K, an increase of 21.58% from the same quarter last year. In Q1, Lexaria Bioscience's net income was $-2.70M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 464.28K$ 226.21K$ 255.40K$ 722.74K$ 384.54K
Gross Profit
$ 459.46K$ 194.71K$ 183.56K$ 547.39K$ 285.17K
Operating Expenses
$ 6.21M$ 6.73M$ 7.57M$ 6.23M$ 4.27M
Depreciation and Amortization
$ 76.15K$ 145.40K$ 146.91K$ 147.60K$ 146.09K
EBITDA
$ -5.68M$ -6.39M$ -6.52M$ -5.58M$ -4.00M
Operating Income
$ -5.75M$ -6.53M$ -7.38M$ -5.69M$ -3.89M
Other Income/Expenses
$ -55.52K$ -178.50K$ -764.61K$ 1.52M$ 0.00
Pretax Income
$ -5.81M$ -6.71M$ -7.38M$ -4.16M$ -4.08M
Net Income
$ -5.80M$ -6.66M$ -7.27M$ -2.50M$ -4.03M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.47$ -1.01$ -1.24$ -0.57$ -1.45
Diluted EPS
$ -0.47$ -1.01$ -1.24$ -0.57$ -1.45
Weighted Average Shares Outstanding
12.38M 6.61M 5.89M 4.39M 2.77M
Weighted Average Shares Outstanding (Diluted)
12.38M 6.61M 5.89M 4.39M 2.77M
Currency in USD

Lexaria Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis